Sales & Marketing Sponsored 12 Questions with Dr James Burt James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.